BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11932138)

  • 41. [Current data on the antibiotic sensitivity of Streptococcus pneumoniae (Pneumococcus). The significance of penicillin resistant isolates].
    Reinert RR; Lütticken R; Kaufhold A
    Med Klin (Munich); 1993 Jun; 88(6):357-61. PubMed ID: 8336662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental efficacy of combined ceftriaxone and amoxycillin on penicillin-resistant and broad-spectrum cephalosporin-resistant Streptococcus pneumoniae infection.
    Chavanet P; Dalle F; Delisle P; Duong M; Pechinot A; Buisson M; D'Athis P; Portier H
    J Antimicrob Chemother; 1998 Feb; 41(2):237-46. PubMed ID: 9533466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L.
    Rodríguez-Cerrato V; Gracia M; Del Prado G; Huelves L; Naves P; Ruiz V; Ponte C; Soriano F
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):336-8. PubMed ID: 19939599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
    Tweardy DJ; Jacobs MR; Speck WT
    J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bactericidal activity of netilmicin compared with gentamicin and streptomycin, alone and in combination with penicillin, against penicillin tolerant viridans streptococci and enterococci.
    Shanson DC; Tadayon M; Bakhtiar M
    J Antimicrob Chemother; 1986 Oct; 18(4):479-90. PubMed ID: 3095305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Penicillin resistance and aminoglycoside-penicillin synergy in enterococci.
    Lopardo HA; Venuta ME; Rubeglio EA
    Chemotherapy; 1995; 41(3):165-71. PubMed ID: 7656661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Carbon C; Gutmann L
    J Infect Dis; 1991 Nov; 164(5):888-93. PubMed ID: 1940467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of susceptibility test methods to detect penicillin susceptibility in Streptococcus pneumoniae isolates.
    Mohd Nasir MD; Parasakthi N
    Malays J Pathol; 2004 Jun; 26(1):29-33. PubMed ID: 16190104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro synergy of penicillin, ceftriaxone and levofloxacin against serotype 19A Streptococcus pneumoniae.
    Tsai HY; Liao CH; Liu CY; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2015 Dec; 46(6):722-5. PubMed ID: 26453149
    [No Abstract]   [Full Text] [Related]  

  • 50. High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium.
    Torres C; Tenorio C; Lantero M; Gastañares MJ; Baquero F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2427-31. PubMed ID: 8285628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
    Klugman KP; Capper T; Bryskier A
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2802-4. PubMed ID: 9124844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-vitro activities of 16 non-beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1999 Apr; 43(4):563-7. PubMed ID: 10350388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
    Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
    Thornsberry C; Burton PH; Vanderhoof BH
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative in vitro activities of carbapenem antimicrobial agents against 264 penicillin-resistant Streptococcus pneumoniae isolates from Korea.
    Choi SH; Park SJ; Jun JB; Lee SR; Jeon MH; Kwon HH; Kim SC; Kim MN; Jeong JY; Woo JH; Kim YS
    Diagn Microbiol Infect Dis; 2007 May; 58(1):141-3. PubMed ID: 17368803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative in-vitro activity of moxifloxacin, penicillin, ceftriaxone and ciprofloxacin against pneumococci isolated from meningitis.
    Tarasi A; Capone A; Tarasi D; Cassone M; Bianco G; Venditti M
    J Antimicrob Chemother; 1999 Jun; 43(6):833-5. PubMed ID: 10404324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative in-vitro activity of quinupristin/dalfopristin (RP 59500) tested against penicillin-and macrolide-resistant pneumococci by the Etest.
    Biedenbach D; Wanger A; Jones RN
    J Antimicrob Chemother; 1996 Sep; 38(3):553-5. PubMed ID: 8889731
    [No Abstract]   [Full Text] [Related]  

  • 58. The in-vitro activities of co-amoxiclav and other oral antibiotics against Streptococcus pneumoniae isolates exhibiting intermediate susceptibility to penicillin.
    Washington JA; Felmingham D
    J Antimicrob Chemother; 1998 Sep; 42(3):405-6. PubMed ID: 9786488
    [No Abstract]   [Full Text] [Related]  

  • 59. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
    Patel R; Rouse MS; Piper KE; Steckelberg JM
    Diagn Microbiol Infect Dis; 2000 Nov; 38(3):177-9. PubMed ID: 11109018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.